Deep Learning Reconstruction Algorithms in Dual Low-dose CTA

April 16, 2024 updated by: Hao Tang

Evaluation of Deep Learning Reconstruction Algorithms in Dual Low-dose CT Vascular Imaging

The goal of this observational study is to evaluate the impact of deep learning image reconstruction on the image quality and diagnostic performance of double low-dose CTA. The main question it aims to answer is to explore the feasibility of deep learning image reconstruction in double low-dose CTA.

Study Overview

Status

Recruiting

Conditions

Detailed Description

  1. The raw data from patients who underwent head and neck CTA, coronary CTA, and abdominal CTA in both standard dose and double low-dose groups were included.
  2. Techniques such as filtered back projection, iterative reconstruction, and deep learning reconstruction were performed.
  3. The feasibility of deep learning reconstruction in double low-dose CTA was evaluated based on image quality and diagnostic performance.

Study Type

Observational

Enrollment (Estimated)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Hubei
      • Wuhan, Hubei, China, 430000
        • Recruiting
        • Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and Technology
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Healthy or diseased adults undergoing CT vascular imaging

Description

Inclusion Criteria:

  • Patients with head and neck CTA, coronary artery CTA, and abdominal CTA due to stroke, coronary heart disease and abdominal inflammatory disease, and abdominal tumors.

Exclusion Criteria:

  • Age <18 years, pregnancy, allergic reaction to iodine contrast agent, renal insufficiency, and severe hyperthyroidism.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Standard dose group
Raw data from 400 patients with conventional dose head and neck CTA, coronary CTA, and abdominal CTA were included. Filtered back-projection, iteration, and deep learning reconstruction were performed. To evaluate the impact of deep learning reconstruction on image quality and diagnostic performance in patients with conventional dose CTA.
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years. It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.
Double low dose group
Raw data from 800 patients with low tube voltage and contrast medium head and neck CTA, coronary CTA, and abdominal CTA were included. Filtered back-projection, iteration, and deep learning reconstruction were performed. To evaluate the impact of deep learning reconstruction on image quality and diagnostic performance in patients with double-low-dose CTA.
Deep learning image reconstruction (DLIR) is a newly developed artificial intelligence noise reduction algorithm in recent years. It trains massive high-quality FBP data sets to learn to distinguish noise and signal, so as to selectively reduce noise and reconstruct high-quality images with low-quality image data.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The specificity and sensitivity calculated through the optimal cutoff value of the receiver operating characteristic curve.
Time Frame: 2026.1
The specificity and sensitivity were calculated separately for the standard dose group and the double low-dose group using the optimal cutoff value from the receiver operating characteristic curve, for the purpose of comparing diagnostic accuracy between the two groups.
2026.1

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The signal-to-noise ratio calculated from image CT values and noise
Time Frame: 2026.1
The signal-to-noise ratio was calculated separately for the standard dose group and the double low-dose group using image CT values and noise, to assess the image quality between the two groups.
2026.1

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Hao Tang, Doctor, Tongji Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

December 1, 2025

Study Completion (Estimated)

March 1, 2026

Study Registration Dates

First Submitted

April 11, 2024

First Submitted That Met QC Criteria

April 16, 2024

First Posted (Actual)

April 18, 2024

Study Record Updates

Last Update Posted (Actual)

April 18, 2024

Last Update Submitted That Met QC Criteria

April 16, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 102122

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

To protect the participant privacy, the relevant data is not shared until the participants' consent

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Deep Learning

Clinical Trials on Deep learning image reconstruction

Subscribe